The Role of High-Level Isolation Units in Response to High-Consequence and Emerging Infectious Diseases: Experience of the German STAKOB Network
Health Security · 01.09.2024 · 22 (1_suppl)
DOI: 10.1089/hs.2023.0156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Security, online erschienen am 11.09.2024. Verfasst von Michaela Niebank und 12 weiteren Autor:innen. Beteiligte Einrichtung: Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and …. Hauptthemen laut MEDLINE: Communicable Diseases, Emerging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This case study describes the experience of the German Permanent Working Group of Competence and Treatment Centers for High Consequence Infectious Diseases, known as STAKOB ( Ständiger Arbeitskreis der Kompetenz- und Behandlungszentren für Krankheiten durch hochpathogene Erreger ). STAKOB brings together public health authorities (competence centers) and high-level isolation units (treatment centers) to collaborate on the clinical management of high-consequence infectious diseases (HCIDs) and emerging infectious diseases. The network is coordinated by the Robert Koch Institute, Germany’s federal public health institute. The main tasks of STAKOB are to strengthen HCID clinical and public health management and increase expert knowledge on HCID and non-HCID emerging infectious diseases in Germany. STAKOB enables the exchange of knowledge and experiences; development of guidelines on infection prevention and control measures, clinical management, and therapy; and support for the World Health Organization and other outbreak responses internationally. The past years have shown how important the STAKOB network is for Germany—not only in providing critical care for HCID cases but also increasing capacity to support public health and clinical management of emerging infectious disease cases. However, maintaining several high-level isolation units in Germany requires a high commitment of financial, material, and human resources. Due to the rarity of HCID and emerging infectious disease events, maintaining the appropriate level of preparedness and ensuring sufficient investments is an ongoing struggle. Nevertheless, it is essential to have a network ready to react to HCID and non-HCID emerging infectious diseases in times of a changing biosecurity and infectious landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats…
Zitieren
APA
Niebank, M., Brockmann, S. O., Feldt, T., Jensen, B. O., Jurke, A., Mikolajewska, A., Rothfuss, K., Schauer, J., Schmiedel, S., Stegemann, M., Tinnemann, P., Uhrig, A., & Wolf, T. (2024). The Role of High-Level Isolation Units in Response to High-Consequence and Emerging Infectious Diseases: Experience of the German STAKOB Network. Health Security, 22(1_suppl). https://doi.org/10.1089/hs.2023.0156
Vancouver
Niebank M, Brockmann SO, Feldt T, Jensen BO, Jurke A, Mikolajewska A, et al. The Role of High-Level Isolation Units in Response to High-Consequence and Emerging Infectious Diseases: Experience of the German STAKOB Network. Health Security. 2024;22(1_suppl). doi:10.1089/hs.2023.0156
BibTeX
@article{Niebank2024,
author = {Niebank, Michaela and Brockmann, Stefan O and Feldt, Torsten and Jensen, Björn-Erik Ole and Jurke, Annette and Mikolajewska, Agata and Rothfuss, Katja and Schauer, Jennifer and Schmiedel, Stefan and Stegemann, Miriam and Tinnemann, Peter and Uhrig, Alexander and Wolf, Timo},
title = {The Role of High-Level Isolation Units in Response to High-Consequence and Emerging Infectious Diseases: Experience of the German STAKOB Network},
journal = {Health Security},
year = {2024},
volume = {22},
number = {1_suppl},
doi = {10.1089/hs.2023.0156}
}
EUVIMED